NEW Enterprise Associates 13 L.P., 10% Owner at Ra Pharmaceuticals, Inc. (RARX), bought 338,462 shares at $13.00 ($4.4M) on 2016-10-31, disclosed to the SEC on 2016-10-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| TSRO | BUY | 2018-03-06 | $6.7M | — | Filing → |
| EPZM | BUY | 2016-01-12 | $10.0M | — | Filing → |
| DERM | BUY | 2014-10-08 | $1.1M | — | Filing → |